Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Hepatitis C

  Free Subscription


Articles published in Clin Res Hepatol Gastroenterol

Retrieve available abstracts of 35 articles:
HTML format



Single Articles


    June 2021
  1. EL-BARAKY IA, Abbassi MM, Ebied FS, Hassany M, et al
    Beta-Thalassemia Major alters Sofosbuvir/Ledipasvir exposure in Hepatitis-C virus Infected Adolescent Patients.
    Clin Res Hepatol Gastroenterol. 2021 Jun 26:101747.
    PubMed     Abstract available


    April 2021
  2. NABATCHIKOVA EA, Abdurakhmanov DT, Rozina TP, Nikulkina EN, et al
    Delisting and clinical outcomes of liver transplant candidates after hepatitis C virus eradication: A long-term single-center experience.
    Clin Res Hepatol Gastroenterol. 2021 Apr 27:101714.
    PubMed     Abstract available


  3. TREPO C
    THE 2020 NOBEL PRIZE OF MEDICINE FOR THREE HEPATITIS C DISCOVERY PIONEERS : A MEDICAL HISTORY MILESTONE.
    Clin Res Hepatol Gastroenterol. 2021 Apr 10:101689.
    PubMed    


    March 2021
  4. AL-KHAYKANEE AM, Abdel-Rahman AA, Essa A, Gadallah AA, et al
    Genetic polymorphism of fibroblast growth factor receptor 2 and trinucleotide repeat-containing 9 influence the susceptibility to HCV-induced hepatocellular carcinoma.
    Clin Res Hepatol Gastroenterol. 2021;45:101636.
    PubMed     Abstract available


  5. LAZARUS JV, Picchio CA, Guy D, Aleman S, et al
    Hepatitis C standards of care: A review of good practices since the advent of direct-acting antiviral therapy.
    Clin Res Hepatol Gastroenterol. 2021;45:101564.
    PubMed     Abstract available


    February 2021
  6. ROGER S, Ducancelle A, Le Guillou-Guillemette H, Gaudy C, et al
    HCV virology and diagnosis.
    Clin Res Hepatol Gastroenterol. 2021;45:101626.
    PubMed     Abstract available


  7. ROUDOT-THORAVAL F
    Epidemiology of hepatitis C virus infection.
    Clin Res Hepatol Gastroenterol. 2021;45:101596.
    PubMed     Abstract available


    November 2020
  8. PARLATI L, Hollande C, Pol S
    Treatment of hepatitis C virus infection.
    Clin Res Hepatol Gastroenterol. 2020 Nov 30:101578.
    PubMed     Abstract available


  9. BOLETO G, Vieira M, Saadoun D, Cacoub P, et al
    Hepatitis C virus-related vasculitis.
    Clin Res Hepatol Gastroenterol. 2020 Nov 29:101575.
    PubMed     Abstract available


    September 2020
  10. MONTASSER IF, Ibrahim AA, Farid HM, Al Balakosy AM, et al
    De novo hepatocellular carcinoma in cirrhotic hepatitis C virus: Are directly acting antivirals beneficial?
    Clin Res Hepatol Gastroenterol. 2020 Sep 5. pii: S2210-7401(20)30212.
    PubMed     Abstract available


    July 2020
  11. EL-FATTAH MA
    Predictive power of Interleukin-28B gene variants for outcome of Hepatitis C Virus genotype 4 in Egyptians: A systematic review and meta-analysis.
    Clin Res Hepatol Gastroenterol. 2020 Jul 1. pii: S2210-7401(20)30175.
    PubMed     Abstract available


    June 2020
  12. VALLET-PICHARD A, Correas JM, Dorival C, Zoulim F, et al
    Absence of impact of direct acting antivirals for hepatitis C virus on recurrent hepatocellular carcinoma tumor growth in the AFEF/ANRS CO22 Hepather cohort.
    Clin Res Hepatol Gastroenterol. 2020 Jun 25. pii: S2210-7401(20)30152.
    PubMed     Abstract available


    December 2019
  13. ZARSKI JP, David-Tchouda S, Trocme C, Margier J, et al
    Non-invasive fibrosis tests to predict complications in compensated post-hepatitis C cirrhosis.
    Clin Res Hepatol Gastroenterol. 2019 Dec 12. pii: S2210-7401(19)30256.
    PubMed     Abstract available


    September 2019
  14. AGUIAR BF, Campos GRF, Rodrigues JPV, Marques NN, et al
    Baseline resistance associated substitutions in HCV genotype 1 infected cohort treated with Simeprevir, Daclatasvir and Sofosbuvir in Brazil.
    Clin Res Hepatol Gastroenterol. 2019 Sep 12. pii: S2210-7401(19)30181.
    PubMed     Abstract available


    June 2019
  15. GOMEZ PA, Zucker KM, Chang J, Rowley MW, et al
    Severe pretreatment hepatic steatosis influences response to direct acting antiviral therapy for chronic hepatitis C in a real world setting.
    Clin Res Hepatol Gastroenterol. 2019 Jun 14. pii: S2210-7401(19)30101.
    PubMed    


    May 2019
  16. RAMEZANI A, Baesi K, Banifazl M, Mohraz M, et al
    Naturally occurring NS5A and NS5B resistant associated substitutions in HCV and HCV/HIV patients in iranian population.
    Clin Res Hepatol Gastroenterol. 2019 May 9. pii: S2210-7401(19)30043.
    PubMed     Abstract available


    April 2019
  17. SUN Q, Li J, Jin B, Wang T, et al
    Evaluation of miR-331-3p and miR-23b-3p as serum biomarkers for hepatitis c virus-related hepatocellular carcinoma at early stage.
    Clin Res Hepatol Gastroenterol. 2019 Apr 30. pii: S2210-7401(19)30088.
    PubMed     Abstract available


    March 2019
  18. FABRIZIO F, Dixit V, Piergiorgio M
    Hepatitis C virus and mortality among patients on dialysis: A systematic review and meta-analysis.
    Clin Res Hepatol Gastroenterol. 2019 Mar 22. pii: S2210-7401(18)30225.
    PubMed     Abstract available


  19. COSTA VD, Delvaux N, Brandao-Mello CE, Nunes EP, et al
    Prevalence of baseline NS3 resistance-associated substitutions (RASs) on treatment with protease inhibitors in patients infected with HCV genotype 1.
    Clin Res Hepatol Gastroenterol. 2019 Mar 14. pii: S2210-7401(19)30048.
    PubMed     Abstract available


    January 2019
  20. GHAZAL K, Morales O, Barjon C, Dahlqvist G, et al
    Early high levels of regulatory T cells and T helper 1 may predict the progression of recurrent hepatitis C after liver transplantation.
    Clin Res Hepatol Gastroenterol. 2019 Jan 31. pii: S2210-7401(18)30221.
    PubMed     Abstract available


  21. PARLATI L, Pol S
    HCV-infected dialysis patients: History is changing.
    Clin Res Hepatol Gastroenterol. 2019 Jan 4. pii: S2210-7401(18)30279.
    PubMed    


    December 2018
  22. CUNHA LRD, Vieira DA, Giampietro YG, Gomes AD, et al
    Interleukin-10 promoter gene polymorphisms are associated with the first major depressive episode in chronic hepatitis C patients.
    Clin Res Hepatol Gastroenterol. 2018 Dec 24. pii: S2210-7401(18)30276.
    PubMed     Abstract available


    October 2018
  23. ALBERTI A, Angarano G, Colombo M, Craxi A, et al
    Optimizing patient referral and center capacity in the management of chronic hepatitis C: Lessons from the Italian experience.
    Clin Res Hepatol Gastroenterol. 2018 Oct 27. pii: S2210-7401(18)30189.
    PubMed     Abstract available


  24. PARLATI L, Sirmai L, Dupuy CA, Glotz D, et al
    Evidence of HCV recovery after therapy of hepatitis C virus infection by direct acting antivirals.
    Clin Res Hepatol Gastroenterol. 2018 Oct 4. pii: S2210-7401(18)30183.
    PubMed    


    August 2018
  25. MEKKY MA, Abdel-Malek MO, Osman HA, Abdel-Aziz EM, et al
    Efficacy of ombitasvir/paritaprevir/ritonavir/ribavirin in management of HCV genotype 4 and end-stage kidney disease.
    Clin Res Hepatol Gastroenterol. 2018 Aug 27. pii: S2210-7401(18)30147.
    PubMed     Abstract available


    May 2018
  26. PAVONE P, Alfieri G, Corano-Scheri G, Pinacchio C, et al
    Systemic adipokines, hepatokines and interleukin-6 in HCV-monoinfected and HCV/HIV coinfected patients treated with direct antiviral agents (DAAs).
    Clin Res Hepatol Gastroenterol. 2018 May 4. pii: S2210-7401(18)30038.
    PubMed    


    December 2017
  27. NAJAFI FARD S, Schietroma I, Corano Scheri G, Giustini N, et al
    Direct-acting antiviral therapy enhances total CD4+ and CD8+ T-cells responses, but does not alter T-cells activation among HCV mono-infected, and HCV/HIV-1 co-infected patients.
    Clin Res Hepatol Gastroenterol. 2017 Dec 23. pii: S2210-7401(17)30262.
    PubMed     Abstract available


    August 2017
  28. MAROT A, Belaid A, Orlent H, Serste T, et al
    Characteristics of patients with hepatitis B virus and hepatitis C virus dual infection in a Western European country: Comparison with monoinfected patients.
    Clin Res Hepatol Gastroenterol. 2017 Aug 31. pii: S2210-7401(17)30134.
    PubMed     Abstract available


    July 2017
  29. ALI HEA, Abdel Hameed R, Effat H, Ahmed EK, et al
    Circulating microRNAs panel as a diagnostic tool for discrimination of HCV-associated hepatocellular carcinoma.
    Clin Res Hepatol Gastroenterol. 2017 Jul 24. pii: S2210-7401(17)30148.
    PubMed     Abstract available


    May 2017
  30. MASCIA C, Lichtner M, Zuccala P, Vita S, et al
    Active HCV infection is associated with increased circulating levels of interferon-gamma (IFN-gamma)-inducible protein-10 (IP-10), soluble CD163 and inflammatory monocytes regardless of liver fibrosis and HIV coinfection.
    Clin Res Hepatol Gastroenterol. 2017 May 31. pii: S2210-7401(17)30098.
    PubMed     Abstract available


  31. ALGOUD M, Tissot-Dupont H, Menard A, Botta-Fridlund D, et al
    Spontaneous clearance of chronic hepatitis C virus infection in HIV-positive patients, southeastern France.
    Clin Res Hepatol Gastroenterol. 2017 May 16. pii: S2210-7401(17)30096.
    PubMed    


    April 2017
  32. TARAMASSO L, Ricci E, Celesia BM, Bonfanti P, et al
    Co-administration of tenofovir plus protease inhibitor based antiretroviral therapy during sofosbuvir/ledipasvir treatment for HCV infection: Much Ado About Nothing?
    Clin Res Hepatol Gastroenterol. 2017 Apr 21. pii: S2210-7401(17)30085.
    PubMed    


    January 2017
  33. LIAO H, Tan P, Zhu Z, Yan X, et al
    Sofosbuvir in combination with daclatasvir in liver transplant recipients with HCV infection: A systematic review and meta-analysis.
    Clin Res Hepatol Gastroenterol. 2017 Jan 9. pii: S2210-7401(16)30207.
    PubMed     Abstract available


    November 2016
  34. BASSENDINE MF, Nielsen SU, Bridge SH, Felmlee DJ, et al
    Hepatitis C virus and atherosclerosis: A legacy after virologic cure?
    Clin Res Hepatol Gastroenterol. 2016 Nov 10. pii: S2210-7401(16)30138.
    PubMed     Abstract available


    April 2016
  35. QU Y, Li T, Wang L, Liu F, et al
    Efficacy and safety of simeprevir for chronic hepatitis virus C genotype 1 infection: A meta-analysis.
    Clin Res Hepatol Gastroenterol. 2016;40:203-12.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis C is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: